Catalysts
PRODUCTS
-
![Anritsu - XR75]( "Pharmaceutical X-Ray Inspection System for Blister Packaging: XR75")
The XR75 Pharma X-ray is optimized for the quality control of pharmaceutical, nutraceutical, and cosmetic products in thin opaque packaging materials that cannot be inspected manually or with visual systems.
-
![PHSX2-0308-53-13]( "SPDT High Power PIN Switch")
High-power SPDT PIN diode RF switches handle 200W CW with fast 1µs switching, delivering low loss and high isolation for radar, comms, ATE, and defense applications.
-
![MBAL-0250CSP2]( "2-50 GHz Passive MMIC Chip Scale Package 1:2 Balun: MBAL-0250CSP2")
The MBAL-0250CSP2 is a passive monolithic microwave integrated circuit (MMIC) 1:2 balun developed by Marki Microwave, designed to operate across an exceptionally wide frequency range of 2 to 50 GHz.
-
![Vaccine Vials GettyImages-1316775813]( "Automatic High-Speed Visual Inspection Of Pharmaceutical Containers")
CS, MS, VI: Our basic platforms for automatic high-speed inspection of vials, ampules, cartridges, and syringes
All three standard machines inspect up to 600 containers/minute, in addition to vials, ampules, cartridges, and syringes with liquid contents, as well as vials with lyo product. Depending on the inspection requirements, we can integrate any inspection technology of our Seidenader Solutions and add a machine module for leak testing.
-
![orange-county]( "Disinfection")
As the final step before treated wastewater leaves the plant, effective disinfection is extremely important to protect human health, and the maintenance of the environment. This process eliminates pathogenic organisms that cannot be removed by previous treatment steps and reduces the spread of pathogens in the natural ecosystem.
USP’s current offerings include our unrivaled in-house CFD modeling expertise that can be used to optimize the injection, mixing and feed rates of PAA to meet the disinfection requirements of a facility. Also, launching later this year, is our OaSys iCT™ is a novel control approach that optimizes disinfection performance by calculating the optimal chemical dosage that accounts for sources of treatment variability in real time. Available for use with PAA or chlorine.
WHITE PAPERS AND CASE STUDIES
-
![GettyImages-1759287088 patient nurse consultation]( "Reducing The Burden Of Patient Retention And Improving Continuity")
Reducing The Burden Of Patient Retention And Improving ContinuityImmunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.
-
![Expanding Diabetes-Related Eye Health Equity]( "Expanding Diabetes-Related Eye Health Equity")
Expanding Diabetes-Related Eye Health Equity20/20 Onsite, American Diabetes Association and Genentech collaborated on an event to provide immediate diagnostic services, including retinal imaging and visual acuity assessments, directly on-site.
-
![Nordson - extruded tubing]( "Innovative Multilayer Extrusion Technology Solves Product Redesign Challenges")
Innovative Multilayer Extrusion Technology Solves Product Redesign ChallengesA multinational medical device company successfully worked to redesign a component used in cardiovascular surgery.
-
![GettyImages-1372091146 patient ipad]( "Breaking Barriers In ED Treatment: A 100% Recruitment Success!")
Breaking Barriers In ED Treatment: A 100% Recruitment Success!Discover how Palleos achieved full patient enrollment across four countries in record time in an Erectile Dysfunction study.
-
![GettyImages-184960936 fayetteville]( "The City Of Fayetteville's Flood Resiliency In The Face Of Climate Change: Mapping 15 Watersheds")
The City Of Fayetteville's Flood Resiliency In The Face Of Climate Change: Mapping 15 WatershedsThe city of Fayetteville, North Carolina has always had flooding issues, but it’s been getting worse as weather patterns have been changing. They were hit four years in a row by storms Matthew (2016), Irma (2017), Florence (2018), and Dorian (2019).
-
![GettyImages-1987435635 research, planning]( "Rescuing A Global Program For NDA Success")
Rescuing A Global Program For NDA SuccessExplore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
-
![Doctor checking patients skin-GettyImages-1094162454]( "Use Of Epiontis ID In A Phase 2 Psoriasis Trial")
Use Of Epiontis ID In A Phase 2 Psoriasis TrialMirikizumab’s Phase 2 trial explores IL-23 inhibition in psoriasis, measuring immune cell changes to assess its potential for long-term disease control and flare-up prevention.
-
![Naples-ARFF]( "Naples Aviation Authority ARFF Transition")
Naples Aviation Authority ARFF TransitionIn a groundbreaking effort to help airports transition from harmful PFAS-laden firefighting foams, the Naples Airport Authority enlisted ECT2 to manage the cleanup of PFAS-contaminated vehicles.
-
![proteoanalyzer-agilent-lab]( "A New Story For Myoglobin—Producing Yeast-Generated Alternative")
A New Story For Myoglobin—Producing Yeast-Generated AlternativeA fast, automated protein analysis workflow empowers researchers to screen yeast strains more efficiently. See how this streamlined approach accelerates innovation while supporting sustainability.
-
![GettyImages-505936413 clinical trials]( "Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis")
Boosting Recruitment Strategy For Phase III Study In Ulcerative ColitisLearn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.
-
![Mettler-Toledo - x-ray inspection]( "X-Ray Inspection For Supplement Safety")
X-Ray Inspection For Supplement SafetyWellington Foods ensures dietary supplement safety using METTLER TOLEDO’s X37 X-ray system, which detects contaminants, and meets regulatory standards with high-speed, precise inspection technology.
-
![GettyImages-1585070896-patient-bandage]( "Expanding Accessibility In A Phase 3 Influenza Study Through Community-Based Research")
Expanding Accessibility In A Phase 3 Influenza Study Through Community-Based ResearchBy meeting participants where they are, this study sets a new benchmark for inclusive, efficient, and impactful vaccine development.
NEWS
-
PulpFixin Announces Strategic Distribution Partnership With Wildcat Laboratory Solutions To Expand Sustainable Lab Products Across The UK And EU4/14/2025
PulpFixin, an innovator of sustainable laboratory products, announced today a new distribution partnership with Wildcat Laboratory Solutions a leading provider of lab equipment and solutions across the United Kingdom and European Union.
-
Puraffinity Signs First Commercial Agreement For Full-Scale Deployment Of Its PFAS Removal Technology6/2/2025
The agreement was signed with Envytech Solutions, the leading expert in mobile water treatment in the Nordic region and a member of the Sortera Group, which operates across the Nordics and the UK.
-
Vodafone Reduces Its Advertising And Media Carbon Footprint By A Third1/7/2025
Vodafone has reduced the carbon footprint of its media and advertising activities by more than a third in a year across thirteen markets in total after benchmarking its media-related greenhouse gas (‘GHG') emissions and introducing global guidelines to mitigate them.
-
U.S. Department Of Energy Announces $6.9M In Projects To Support Effective Community Waste-To-Energy Strategies For Local Transportation Needs1/7/2025
The U.S. Department of Energy's (DOE) Bioenergy Technologies Office (BETO) and Vehicle Technologies Office (VTO) announced $6.9M in funding for nine projects to support local waste-to-energy management solutions for transportation energy needs.
-
AEON Biopharma Appoints Industry Veteran Rob Bancroft As Chief Executive Officer4/21/2025
AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced today the appointment of Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft will also join AEON’s Board of Directors.
ABOUT
Catalysts
Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy. For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.
Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.
All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present. When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.
Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst. Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.
Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature. Applications of this technology include oil and petrochemical industries.